ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Budget Manipulations “Wreaking Havoc,” Korn Tells NCAB; Legal Actions Being Considered

February 13, 1987

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

DES-Breast Cancer Risk Studies Concept approved

March 7, 1986

CMS Inserts Unprecedented Conditions Into Medicare Coverage of Lung Screening

November 14, 2014

IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer

October 28, 2011

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001